Therefore, these results raise the question of whether TrkC acts as an oncogenic protein or tumor suppressor in CRC progression and whether NT-3 suppresses TrkC-mediated apoptosis in CRC cells, despite NT-3 and TrkC being reportedly upregulated in normal colon relative to CRC tissues and cells. The gene discussed is NTF3; the disease is colorectal carcinoma.